Skip to main content
. 2012 Mar 31;44(1):50–56. doi: 10.4143/crt.2012.44.1.50

Table 2.

Correlation of AR and EGFR expression with clinicopathologic factors in 66 prostate adenocarcinomas

graphic file with name crt-44-50-i002.jpg

Values are presented as number (%). AR, androgen receptor; EGFR, epidermal growth factor receptor; Pre-op PSA, pre-operative serum total prostate-specific antigen; NS, not significant.